Last reviewed · How we verify

NCT06310122

Effect of Extracorporeal Shockwave Therapy on Gait Parameters in Patients With Planter Fascitis

Status unknown NA Last updated 15 March 2024
What this trial tests

NA trial testing Extracorporeal shockwave therapy in Plantar Fascitis in 52 participants. Status unknown.

Timeline
12 March 2024
Primary endpoint
1 September 2024
30 March 2025

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment52
Start date12 March 2024
Primary completion1 September 2024
Estimated completion30 March 2025

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 40, female only, with Plantar Fascitis or Extracorporeal Shockwave Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is : * to determine the effect of extracorporeal shockwave on pain intensity in patients with plantar fasciitis. * to determine the effect of extracorporeal shockwave on foot function in patients with plantar fasciitis. * to determine the effect of extracorporeal shockwave on gait parameters in patients with plantar fasciitis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Extracorporeal shockwave therapy

Trials testing the same drug.

Other recruiting trials for Plantar Fascitis

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06310122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing